EN1902I Novel Agents in Sickle Cell Disease by Oyebimpe O. Adesina, MD, MS

Instructions

Wednesday, September 26, 2018, 3:00 AM - Saturday, September 25, 2021, 11:59 PM

AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician (1.00 hours)

Enter your weekly promo code in the registration tab to enable the video content.

Oyebimpe O. Adesina, MD, MS
Assistant Professor, Department of Medicine, Division of Hematology
University of Washington

Speaker Disclosures: Dr. Oyebimpe O. Adesina discloses no conflicts of interest.

The following planning members have no financial or other relationship with any commercial interest in the past twelve months: Sindhu Cherian, MD; Daniel Gallego, MD; Nabiha Huq Saifee, MD, PhD; Rhona Jack, PhD; Alex Mays, MD; Joe Rutledge, MD; Brian Shirts MD, PhD; Hamilton Tsang, MD; and Mark Wener, MD.

The following planning members have relevant relationships to disclose: Noah Hoffman, MD, PhD discloses a consulting, speaking and teaching relationship with Bio-Rad; Sean Murphy, MD, PhD discloses being a major stock shareholder in Sound Vaccines Inc. and grant/research support from Novartis Inc.; Daniel Sabath, MD, PhD discloses grant/research support from RareCyte, Inc.

Earn CME Credit:

• You will be required to watch a video recording of the lecture and complete a pre- and post-test.
• A passing score on the post-test will be necessary to receive your CME credit.  The passing score for this activity is 80%.
  This session will take approximately 1 hour to watch the video and complete the post-test.
• In order to receive your certificate of completion, a completed evaluation will be required.

1. Describe the pathophysiology of sickle cell disease (SCD).
2. Distinguish the mechanisms of action of SCD-modifying drugs.
3. Interpret changes in laboratory parameters that correlate with therapeutic benefit of SCD-modifying drugs.

Accreditation with Commendation: The University of Washington School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation: The University of Washington School of Medicine designates this Enduring Material for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

No faculty are available for this activity at this time.